036220.KQ
Osang Healthcare Co.,Ltd
KOE · Healthcare · Medical - Specialties · KR
KRW 6,430.00
−0.62%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 96.5B | 128.6B | 80.5B | 355.8B | 193.9B |
| Cost of Revenue | 66.9B | 74.8B | 54.9B | 134.7B | 97.3B |
| Gross Profit | 29.6B | 53.8B | 25.6B | 221.1B | 96.6B |
| Operating Expenses | |||||
| R&D Expense | 18.1B | 18.9B | 20.0B | 16.6B | 12.1B |
| SG&A Expense | 21.4B | 18.3B | 15.7B | 43.9B | 34.9B |
| General & Admin Expense | 3.8B | 4.8B | 4.5B | 3.9B | 3.2B |
| Selling & Marketing Expense | 8.3B | 13.5B | 11.2B | 40.0B | 17.7B |
| Other Expenses | 11.7B | 15.0B | 14.7B | 17.7B | 805.8M |
| Total Operating Expenses | 51.3B | 52.3B | 50.4B | 78.3B | 47.8B |
| Cost and Expenses | 118.1B | 127.0B | 105.3B | 213.0B | 145.1B |
| Operating Income (EBIT) | (21.1B) | 1.6B | (24.8B) | 144.6B | 48.8B |
| Non-Operating | |||||
| Interest Income | 18.5B | 623.7M | 1.6B | 3.4B | 677.5M |
| Interest Expense | 13.2B | 1.1B | 27.2M | 58.9M | 25.1M |
| Net Interest Income | 5.3B | (485.2M) | 1.6B | 3.3B | 652.4M |
| Other Non-Op Income/Expense | 10.7B | 943.8M | 1.7B | 9.6B | 3.1B |
| Non-Operating Income (excl Interest) | (1.2B) | — | (1.8B) | (10.2B) | (2.3B) |
| EBT (Pre-Tax Income) | (10.3B) | 2.5B | (23.1B) | 152.4B | 51.8B |
| Income Tax Expense | (1.9B) | (576.8M) | (11.7B) | 35.8B | 11.2B |
| Bottom Line | |||||
| Net Income | (8.5B) | 3.1B | (11.4B) | 116.4B | 40.6B |
| Earnings from Cont. Ops | (8.5B) | 3.1B | (11.4B) | 116.7B | 40.7B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (8.5B) | 3.1B | (11.4B) | 116.4B | 40.6B |
| Per Share | |||||
| Basic EPS | (₩601) | ₩226 | (₩837) | ₩9,148 | ₩3,245 |
| Diluted EPS | (₩602) | ₩226 | (₩837) | ₩8,921 | ₩3,168 |
| Revenue Per Share | ₩7,014 | ₩8,865 | ₩5,931 | ₩27,958 | ₩15,479 |
| Shares | |||||
| Basic Shares Outstanding | 13.8M | 14.5M | 13.6M | 12.7M | 12.5M |
| Diluted Shares Outstanding | 13.8M | 14.5M | 13.6M | 13.1M | 12.8M |
| Profitability Metrics | |||||
| EBITDA | (27.8B) | 8.4B | (15.9B) | 157.9B | 57.0B |
| D&A | 8.0B | 6.8B | 7.2B | 6.3B | 5.4B |
| EBIT | (35.8B) | 1.6B | (23.0B) | 151.6B | 51.6B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026